Literature DB >> 19940514

A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: the Women's Health Initiative Magnetic Resonance Imaging study.

Janet A Tooze1, Sarah A Gaussoin, Susan M Resnick, Nancy J Fischbein, Jennifer G Robinson, R Nick Bryan, Yang An, Mark A Espeland.   

Abstract

BACKGROUND: Both the prevalence and extent of brain magnetic resonance imaging (MRI) abnormalities are related to risk factors for dementia. Typically these associations have been explored separately, but an integrated modeling approach would allow the separate relationships to be consistently described and contrasted.
METHODS: Region-specific measures of ischemic lesion volumes were obtained from standardized brain MRI from 1,403 women enrolled in the Women's Health Initiative hormone therapy trials. Mixed-effects mixed-distribution models were fitted to explore jointly the relationships that the region-specific prevalence of ischemic lesions and region-specific ischemic lesion volumes had with risk factors and scores from tests of cognitive function.
RESULTS: Women with greater probabilities (prevalence) of having ischemic lesions in brain regions also tended to have larger volumes (extent) of ischemic lesions within the affected regions (p < 0.001). Across the 5 regions included in analyses (frontal, limbic, occipital, parietal and temporal), prevalence and extent varied (p < 0.001). Each was increased among women who were older, had hypertension or who had previously been classified as cognitively impaired (p < 0.01). Additionally, extent was significantly increased among women with a history of smoking (p = 0.02). Cognitive function tests were more strongly related to the extent than prevalence of ischemic lesions and relationships varied among cognitive domains (p < 0.001).
CONCLUSIONS: Mixed-effects mixed-distribution models provide a coherent basis for examining relationships involving the prevalence and extent of ischemic brain lesions. Across the cohort and regions we examined, relationships with risk factors and cognitive function appeared to be stronger for extent than for prevalence. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19940514      PMCID: PMC2818378          DOI: 10.1159/000260071

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  24 in total

1.  Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study.

Authors:  D M Moody; M A Bell; V R Challa
Journal:  AJNR Am J Neuroradiol       Date:  1990-05       Impact factor: 3.825

2.  The Modified Mini-Mental State (3MS) examination.

Authors:  E L Teng; H C Chui
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

3.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

4.  The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.

Authors:  Susan M Resnick; Laura H Coker; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Sally A Shumaker
Journal:  Clin Trials       Date:  2004       Impact factor: 2.486

Review 5.  Pathogenesis of leukoaraiosis: a review.

Authors:  L Pantoni; J H Garcia
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

6.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

7.  Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study.

Authors:  R N Bryan; J Cai; G Burke; R G Hutchinson; D Liao; J F Toole; A P Dagher; L Cooper
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

8.  Prevalence and volume of internal border zone lesions in patients with impaired cerebral carbon dioxide vasomotor reactivity: a follow-up study.

Authors:  Robertus H C Bisschops; Catharina J M Klijn; L Jaap Kappelle; Alexander C van Huffelen; Jeroen van der Grond
Journal:  Arch Neurol       Date:  2003-09

Review 9.  White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.

Authors:  R Schmidt; Ph Scheltens; T Erkinjuntti; L Pantoni; H S Markus; A Wallin; F Barkhof; F Fazekas
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

10.  The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.

Authors:  S A Shumaker; B A Reboussin; M A Espeland; S R Rapp; W L McBee; M Dailey; D Bowen; T Terrell; B N Jones
Journal:  Control Clin Trials       Date:  1998-12
View more
  3 in total

1.  Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative.

Authors:  M Haan; M A Espeland; B E Klein; R Casanova; S A Gaussoin; R D Jackson; A E Millen; S M Resnick; J E Rossouw; S A Shumaker; R Wallace; K Yaffe
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

2.  Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies.

Authors:  Laura H Coker; Mark A Espeland; Patricia E Hogan; Susan M Resnick; R Nick Bryan; Jennifer G Robinson; Joseph S Goveas; Christos Davatzikos; Lewis H Kuller; Jeff D Williamson; Cheryl D Bushnell; Sally A Shumaker
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

3.  Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study.

Authors:  Bernhard Haring; Xiaoyan Leng; Jennifer Robinson; Karen C Johnson; Rebecca D Jackson; Rebecca Beyth; Jean Wactawski-Wende; Moritz Wyler von Ballmoos; Joseph S Goveas; Lewis H Kuller; Sylvia Wassertheil-Smoller
Journal:  J Am Heart Assoc       Date:  2013-12-18       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.